Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen CorpfiledCriticalNeurogen Corp
Publication of MX9709771ApublicationCriticalpatent/MX9709771A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Disclosed are compounds of formula (I) wherein: T is NH, O, or S; X is hydrogen, hydroxyl, lower alkyl, or an optionally substituted amide; the W ring is an optionally substituted aryl or heteroaryl group; and (a) represents an optionally substituted benzo group or an optionally substituted 5, 6, 7, or 8 membered ring. These compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs of agonists, antagonists or inverse agonists for GABAa brain receptors. These compouns are useful in the diagnosis and treatment of anxiety, sleep and seizure disorders, overdose with benzodiazepine drugs and for enhancement of memory.
MX9709771A1995-06-051997-12-05Novel substituted aryl and cycloalkyl imidazolones; a new class of gaba brain receptor ligands.
MX9709771A
(en)